Abstract
To date, standard recommendations for the management of stress urinary incontinence (SUI) would be either pelvic floor muscle training (PFMT) or surgery. A new form of drug treatment with a serotonin-noradrenaline reuptake inhibitor (SNRI), duloxetine, may now have a place in treatment of this condition.
Original language | English |
---|---|
Pages (from-to) | CD004742 |
Journal | Cochrane Database of Systematic Reviews |
Issue number | 3 |
DOIs | |
Publication status | Published - 2005 |